PRO In-depth

The Pharmaceutical Intellectual Property and Competition Law Review

The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.

Overview

  • Editor's Preface

Jurisdictions

  • Australia Jones Day
  • Brazil Pinheiro Neto Advogados
  • Canada Baker McKenzie
  • France August Debouzy
  • Hungary Danubia Patent and Law Office LLC
  • Japan Mori Hamada & Matsumoto
  • Malaysia Wong & Partners (member firm of Baker McKenzie International)
  • Poland Traple Konarski Podrecki & Partners
  • Portugal Uría Menéndez
  • Russia Herbert Smith Freehills LLP
  • South Korea Lee & Ko
  • Spain Uría Menéndez
  • United Kingdom Bird & Bird LLP
  • USA Arnold & Porter